Summary of the Proceedings from the 10th Annual Meeting of Molecularly Targeted Therapy in Non-small Cell Lung Cancer
Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
Poly(ADP-Ribose) Polymerase Inhibitors
Fibroblast Growth Factor Inhibitors
Histone Deacetylase, Proteasome, and Heat Shock Protein Inhibitors for the Treatment of Lung Cancer
Cell Cycle-Associated Kinases as Targets for Therapy in Lung Cancer
Vaccines and Immunotherapy for Non-small Cell Lung Cancer
Src Inhibitors
Novel Drugs—Miscellaneous Category
Epidermal Growth Factor Receptor Pathway
Supportive Care
MEK/MAPK Inhibitors
Insulin-Like Growth Factor Pathway
Proapoptotic Agents in Lung Cancer
Vascular Disrupting Agents
Targeting Vascular Endothelial Growth Factor in Lung Cancer
Mammalian Target of Rapamycin, Akt, and Phosphatidylinositol 3-Kinase Signaling
Novel Taxanes/Epothilones
Cancer Stem Cells and Targeting Embryonic Signaling Pathways
EML4/ALK and Ras Inhibitors